Patients self-administer the drug using a pre-dosed injector pen, but Lilly recently introduced the product in single-dose ...
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
Alix Harvey, a 35-year-old marine biologist from Plymouth, welcomed the move to increase access to the weight-loss drug. She ...
However, Dr Kath McCullough, NHS England’s national speciality adviser for obesity, warned that weight loss jabs “are not a ...
Zepbound, a drug with the main active ingredient tirzepatide, was found to be more helpful in helping people lose weight than ...
A new weight-loss jab will be rolled out on the NHS in England - but it could take 12 years for everyone to receive it, the ...
Even as weight-loss drugs such as Wegovy and Zepbound explode in popularity, many Americans struggle to afford them.
Shares of Eli Lilly climbed early Wednesday after the drugmaker detailed a study showing that its blockbuster weight-loss ...
Eli Lilly & Co. is spending another $3 billion to build out its US manufacturing footprint as it ramps up production of its ...
“Mounjaro is the brand name for tirzepatide, a weekly injectable weight-loss medication which has recently been approved for ...
The rollout of the weight-loss drug to 3.4 million eligible patients could take up to 12 years, according to NICE.
A new drug dubbed the “King Kong” of weight-loss jabs will be available in Ireland early next year, it was confirmed ...